Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay

1918.096 - 1941.694 Dr. Rana McKay

This is the imaging. Here's the teaching. And I think that that really kind of takes out a lot of bias from the process. So I think standardization is important and also kind of seeing what the goals are for the patient and aligning with them is really key. I think what's really cool that's coming down the pike is, you know, we continue to bat away at the androgen receptor in prostate cancer.